Forschung
Lehre
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medicine,
Helen Diller Family Comprehensive Cancer Center
Collin M. Blakely has not added Biography.
If you are Collin M. Blakely and would like to personalize this page please email our Author Liaison for assistance.
Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.
Clinical lung cancer 03, 2019 | Pubmed ID: 30553716
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 01, 2020 | Pubmed ID: 31548343
A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research 12, 2019 | Pubmed ID: 31611281
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.
Cell 09, 2020 | Pubmed ID: 32822576
University of California, San Francisco
Dora Barbosa Rabago1,2,3,
Collin M. Blakely1,2,
Franziska Haderk1,2,3,
Trever G. Bivona1,2,3
1Department of Medicine, University of California, San Francisco,
2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,
3Department of Cellular and Molecular Pharmacology, University of California, San Francisco
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten